•
Dec 31, 2012

PTC Therapeutics Q4 2012 Earnings Report

Total Revenue
$5.92M
EPS
$37.4
Previous year: $24
+55.9%
Cash and Equivalents
$2.73M
Previous year: $28.4M
-90.4%
Total Assets
$13.1M

PTC Therapeutics

PTC Therapeutics